FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885816098> ?p ?o ?g. }

• W2885816098 endingPage "128" @default.
• W2885816098 startingPage "128" @default.
• W2885816098 abstract "(1) Background: Andrographolide (AG) is a natural compound effective for the treatment of inflammation-mediated neurodegenerative disorders. The aim of this investigation was the preparation of liposomes to enhance the penetration into the brain of AG, by modifying the surface of the liposomes by adding Tween 80 (LPs-AG) alone or in combination with Didecyldimethylammonium bromide (DDAB) (CLPs-AG). (2) Methods: LPs-AG and CLPs-AG were physically and chemically characterized. The ability of liposomes to increase the permeability of AG was evaluated by artificial membranes (PAMPA) and hCMEC/D3 cells. (3) Results: Based on obtained results in terms of size, homogeneity, ζ-potential and EE%. both liposomes are suitable for parenteral administration. The systems showed excellent stability during a month of storage as suspensions or freeze-dried products. Glucose resulted the best cryoprotectant agent. PAMPA and hCMEC/D3 transport studies revealed that LPs-AG and CLPs-AG increased the permeability of AG, about an order of magnitude, compared to free AG without alterations in cell viability. The caveolae-mediated endocytosis resulted the main mechanism of up-take for both formulations. The presence of positive charge increased the cellular internalization of nanoparticles. (4) Conclusions: This study shows that developed liposomes might be ideal candidates for brain delivery of AG." @default.
• W2885816098 created "2018-08-22" @default.
• W2885816098 creator A5040495445 @default.
• W2885816098 creator A5041901658 @default.
• W2885816098 creator A5055870027 @default.
• W2885816098 creator A5070522238 @default.
• W2885816098 creator A5083083386 @default.
• W2885816098 creator A5083113704 @default.
• W2885816098 date "2018-08-13" @default.
• W2885816098 modified "2023-10-01" @default.
• W2885816098 title "Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability" @default.
• W2885816098 cites W1482904772 @default.
• W2885816098 cites W1786633887 @default.
• W2885816098 cites W1963509607 @default.
• W2885816098 cites W1967131786 @default.
• W2885816098 cites W1993760429 @default.
• W2885816098 cites W2004655157 @default.
• W2885816098 cites W2017925961 @default.
• W2885816098 cites W2018121350 @default.
• W2885816098 cites W2018638665 @default.
• W2885816098 cites W2026976753 @default.
• W2885816098 cites W2032856871 @default.
• W2885816098 cites W2033397840 @default.
• W2885816098 cites W2034186281 @default.
• W2885816098 cites W2035669214 @default.
• W2885816098 cites W2039444865 @default.
• W2885816098 cites W2041071750 @default.
• W2885816098 cites W2059877047 @default.
• W2885816098 cites W2061863138 @default.
• W2885816098 cites W2066844739 @default.
• W2885816098 cites W2070902035 @default.
• W2885816098 cites W2073101936 @default.
• W2885816098 cites W2076949199 @default.
• W2885816098 cites W20814817 @default.
• W2885816098 cites W2083306019 @default.
• W2885816098 cites W2090088751 @default.
• W2885816098 cites W2097047268 @default.
• W2885816098 cites W2104276418 @default.
• W2885816098 cites W2115924220 @default.
• W2885816098 cites W2139333712 @default.
• W2885816098 cites W2139835982 @default.
• W2885816098 cites W2147860168 @default.
• W2885816098 cites W2154494407 @default.
• W2885816098 cites W2155436051 @default.
• W2885816098 cites W2192933335 @default.
• W2885816098 cites W2266148525 @default.
• W2885816098 cites W2300671107 @default.
• W2885816098 cites W2329297051 @default.
• W2885816098 cites W2342921077 @default.
• W2885816098 cites W2416229138 @default.
• W2885816098 cites W2559141477 @default.
• W2885816098 cites W2589877128 @default.
• W2885816098 cites W2617943552 @default.
• W2885816098 cites W2636979619 @default.
• W2885816098 cites W2768052566 @default.
• W2885816098 cites W4237265498 @default.
• W2885816098 doi "https://doi.org/10.3390/pharmaceutics10030128" @default.
• W2885816098 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6161272" @default.
• W2885816098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30104484" @default.
• W2885816098 hasPublicationYear "2018" @default.
• W2885816098 type Work @default.
• W2885816098 sameAs 2885816098 @default.
• W2885816098 citedByCount "50" @default.
• W2885816098 countsByYear W28858160982019 @default.
• W2885816098 countsByYear W28858160982020 @default.
• W2885816098 countsByYear W28858160982021 @default.
• W2885816098 countsByYear W28858160982022 @default.
• W2885816098 countsByYear W28858160982023 @default.
• W2885816098 crossrefType "journal-article" @default.
• W2885816098 hasAuthorship W2885816098A5040495445 @default.
• W2885816098 hasAuthorship W2885816098A5041901658 @default.
• W2885816098 hasAuthorship W2885816098A5055870027 @default.
• W2885816098 hasAuthorship W2885816098A5070522238 @default.
• W2885816098 hasAuthorship W2885816098A5083083386 @default.
• W2885816098 hasAuthorship W2885816098A5083113704 @default.
• W2885816098 hasBestOaLocation W28858160981 @default.
• W2885816098 hasConcept C120882062 @default.
• W2885816098 hasConcept C12554922 @default.
• W2885816098 hasConcept C127413603 @default.
• W2885816098 hasConcept C13245373 @default.
• W2885816098 hasConcept C1491633281 @default.
• W2885816098 hasConcept C178790620 @default.
• W2885816098 hasConcept C185154212 @default.
• W2885816098 hasConcept C185592680 @default.
• W2885816098 hasConcept C2777239854 @default.
• W2885816098 hasConcept C2779820397 @default.
• W2885816098 hasConcept C2781357234 @default.
• W2885816098 hasConcept C28005876 @default.
• W2885816098 hasConcept C41625074 @default.
• W2885816098 hasConcept C42475967 @default.
• W2885816098 hasConcept C43617362 @default.
• W2885816098 hasConcept C55493867 @default.
• W2885816098 hasConcept C71924100 @default.
• W2885816098 hasConcept C80107235 @default.
• W2885816098 hasConcept C86803240 @default.
• W2885816098 hasConcept C98274493 @default.
• W2885816098 hasConceptScore W2885816098C120882062 @default.
• W2885816098 hasConceptScore W2885816098C12554922 @default.

• next